Scott Bratman

Co-Founder and CEO

Scott Bratman picture

Scott Bratman

Adela

Co-Founder and CEO

Dr. Scott Bratman is Co-Founder, President, and CEO of Adela (formerly DNAMx), a company that has recently completed its Series A financing with strong VC backing. Adela’s mission is to develop innovative and accessible technologies that harness biology and change the way we diagnose and treat disease. Prior to joining Adela, Scott has been a physician-scientist known for developing novel liquid biopsy methods with immense clinical impact. Scott’s groundbreaking research at Stanford University advanced the practice of mutation detection within cell-free DNA, which is now commonplace in oncology clinics. As Principal Investigator at University of Toronto and Princess Margaret Cancer Centre, Scott’s research program has continued to produce fundamental discoveries in cell-free DNA biology, technologies, and applications. Scott holds a BA in Molecular Biology from Princeton University and an MD/PhD from Columbia University.